Biliary excretion of rufloxacin in humans.

Rufloxacin is a new once-daily antibacterial fluoroquinolone with a long half-life. The aim of the present study was to evaluate the plasma and biliary kinetics and biliary and urinary excretion of rufloxacin in patients with extrahepatic cholestasis. Twelve patients with total external percutaneous...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Privitera, G, Nicastro, G, Imbimbo, B P, Cesana, M, Visconti, M, Lombardi, F, Tagliabue, G, Faleschini, E, Colturani, F, Franzini, P
Médium: Artigo
Jazyk:Inglês
Vydáno: 1993
Témata:
Research Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC192734/
https://ncbi.nlm.nih.gov/pubmed/8109915
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky